" Republicans are handing the election over to whoever runs on the Dem ticket."
It is way too early to be making bold predictions like this. I happen to think Hillary is not electable either, or I hope so anyhow.
They would not have moved to the Nasdaq if they needed to raise money in the near term. You really should get your head out of your asss and stop talking about pre-split prices. That is totally irrelevant to today or the future.
Donald Trump doesn't seem concerned about coalition building inside the party, and he could care less what other people think either. I'm not aware of his opinion on stem cells though, and I still have my doubts that he is electable.
You mentioned that you also own some Osiris, but I would want to stay far away from any company with live stem cells if the Republicans win the White House. The religious right still has a big influence in getting candidates elected, and live stem cells have always been an issue in the past. MiMedx doesn't have this same issue.
If there is any truth to what you are saying, then Pete needs to cleanup all the foul mouth garbage like you on these message boards. I don't mind seeing a little more money going to litigation expense, nor do I really care if you think John and Randall were treated fairly. John Daniel sold his company. He got paid well. Case closed.
I believe it is Margaret rather than Mary, and it is MiMedx rather than MIMEDEX. Although I agree there was wrongdoing with the untitled letter, I doubt liberal or conservative had much to do with it. I believe the action was prompted by a competitor or a short seller for money. It has become too easy every time a stock drops to blame it on Obama, but I seriously doubt Obama has ever even heard of MiMedx.
"seems attractive at these levels (aside from the overall markets sinking all boats right now). soon back to $13 in my opinion based on last earnings call and guidance."
I know when we start hearing from short sellers like how_about_we_short saying it was "priced to perfection" at $13 that we will be at $15 or higher on the next run. Profit margins were cut 2% for the rest of 2015. This selloff makes about as much sense as the selloff in January over the bogus qui tam action. The short sellers have proven they need very little reason to add to their short position in this stock.
This is a very positive sign. If we are up or holding our own in a down market, then the stock will run when the market has bottomed. Chicken Little will say the sky is falling now, but the markets will rise again.
I'm not as interested in recouping patent litigation expenses as I am in that 50 million in Medline revenue. Who would be better than a former Medline salesman in talking to a former Medline customer about their wound care needs? If Pete sacrificed some net profit in 2015 to dramatically raise revenue in 2016, then I applaud the decision. Some of the analysts asked if guidance would be raised for 2015, but Medline isn't pulling out until September. I wouldn't expect to see most of that Medline revenue until the first half of 2016.
"In addition, look for the sales folks to jump on any large orders previous sold by these infringing parties."
You are spot on again njbugatti. My thoughts exactly. MiMedx stock has been mutilated by short sellers because the company invested money in legal fees to protect their patents? This is a usual and necessary part of running a business. Net profits will drop for the balance of 2015 because Pete saw an investment opportunity too good to pass up? Was that investment opportunity hiring some of the best Medline salesmen to go after that 50 million of Medline revenue? It looks now like some of that 50 million of Medline revenue might have been ill gotten gain anyhow.
"If you're counting on lawsuits to improve the bottom line, you'll have very very long wait."
Didn't I hear on the last conference call that Medline was pulling out of wound care in September, and leaving about 50 million in sales up for grabs? If MiMedx takes the lion share of that 50 million, then the wait might not be as long as you think?
Didn't I also hear that net profit margins would be lower for the balance of 2015 because Pete decided to make an investment he thought would be very profitable in the future? I would consider that Medline business to be very profitable.
It is always difficult for me to understand how a company can lose 2.5% of its market capitalization from the trading on 5000 shares of stock. That is what has happened so far this morning. Even 5000 shares traded at $6 would only equal $30,000, yet the company has lost 2.5% of market capitalization in 15 minutes. Microcap stocks are volatile, but this market maker is absurd.
It could be just a case of buy on the rumor and sell om the news. Shares were purchased a little over a week ago for $5, and dumped on the open for a quick 25% gain. This stock will be much higher in 9 months although most traders playing in microcap biotech don't want to wait that long.